Renal thrombotic microangiopathies induced by severe hypertension

Hypertension Research

Volumn 31, Issue 3, 2008, Pages 479-483

  Zhang, Bo ^a   Xing, Changying ^a   Yu, Xiangbo ^a   Sun, Bin ^a   Zhao, Xiufen ^a   Qian, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Hypertension; Kidney; Microangiopathy

Indexed keywords

ANTIGEN; CREATININE; LACTATE DEHYDROGENASE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; ADULT; ARTERIOLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HEMATURIA; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; KIDNEY ARTERY; KIDNEY BIOPSY; KIDNEY FUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MALIGNANT HYPERTENSION; PROTEINURIA; RENOVASCULAR DISEASE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ARTERIOLES; BIOPSY; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; PROTEINURIA; RENAL ARTERY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; THROMBOSIS;

EID: 42649105187     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.479     Document Type: Article

References (20)

1. Moake JL: Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
2. Liapis H: Thrombotic microangiopathy involving the kidney: a histopathologic perspective. Hippokratia 2003; 7: 152-158.
3. Vaughan CJ, Delanty N: Hypertensive emergencies. Lancet 2000; 356: 411-417.
4. Khanna A, McCullough PA: Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure. Rev Cardiovasc Med 2003; 4: 255-259.
5. Egan JA, Bandarenko N, Hay SN, et al: Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura. J Clin Apher 2004; 19: 125-129.
6. Galbusera M, Benigni A, Paris S, et al: Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. J Am Soc Nephrol 1999; 10: 1234-1241.
7. Rick ME, Molls S, Taylor MA: Clinical use of rapid collagen binding assay for von Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpura. Thromb Haemost 2002; 88: 598-604.
8. Kadiri S, Olutade BO: The clinical presentation of malignant hypertension in Nigerians. J Hum Hypertens 1991; 5: 339-343.
9. Espinosa G, Bucciarelli S, Cervera R, et al: Thrombotic microangiopathic haemolytic anemia and antiphospholipid antibodies. Ann Rheum Dis 2004; 63: 730-736.
10. Gurkan E, Baslamisli, Guvenc B, et al: Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases. Clin Lab Haematol 2005; 27: 121-125.
11. Hollenbeck M, Kutkuhn B, Aul C, et al: Haemolytic-uraemic syndrome and thrombotic-thrombocytopenic purpura in adults: clinical findings and prognostic factors for death and end-stage renal disease. Nephrol Dial Transplant 1998; 13: 76-81.
12. Bridoux F, Vrtovsnik F, Noel C, et al: Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival. Nephrol Dial Transplant 1998; 13: 298-304.
13. Farrugia E, Torres VE, Gastineau D, et al: Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis 1992; 20 463-471.
14. Ono H, Ono Y: Nephrosclerosis and hypertension. Med Clin North Am 1997; 81: 1273-1288.
15. Morel-Maroger L, Kanfer A, Solez K, et al: Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome). Clinicopathologic study in 20 adults. Kidney Int 1979; 15:548-558.
16. Schieppati A, Ruggenenti P, Cornejo RP, et al: Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of Haemolytic Uremic Syndrome. J Am Soc Nephrol 1992; 2: 1640-1644.
17. Conlon PJ, Howell DN, Macik G, Kovalik EC, Smith SR: The renal manifestation and outcome of thrombotic thrombocytopenic purpura/ hemolytic uremic syndrome in adults. Nephrol Dial Transplant 1995; 10: 1189-1193.
18. Tsai HM, Chandler WL, Sarode R, et al: von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157: H7-associated hemolytic uremic syndrome. Pediatr Res 2001; 49: 653-659.
19. Moore JC, Hayward CPM, Warkentin TE, et al: Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 2001; 98: 1842-1846.
20. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E: Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001; 98: 2730-2735.